It has been found that Galectin-1 (Gal-1) is an indicator of poor prognosis in ovarian cancer patients where high expression of Gal-1 is observed in ovarian cancers of higher histological grade as well as advanced lymph node status [44, 45]. This evidence concerns the gene LGALS1 and ovarian carcinoma.